Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations
- PMID: 3100598
- DOI: 10.1016/s0735-1097(87)80373-x
Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations
Abstract
Increased levels of an endogenous inhibitor of tissue-plasminogen activator (t-PA) have been thought to relate to the genesis of acute myocardial ischemia. To examine the role of the rapid inhibitor of t-PA, plasma samples were analyzed from 75 patients with chest pain syndrome undergoing coronary angiography (mean age 57 years), 24 patients with clinically documented coronary artery disease (unstable angina, positive exercise stress test or previous history of myocardial infarction; mean age 58 years) and 15 young normal subjects (mean age 26 years). Plasma t-PA inhibitor levels were similar in age-matched patients regardless of the absence or presence (and degree) of coronary artery disease. Plasma t-PA inhibitor levels correlated significantly with age (r - 0.46, p less than 0.005), suggesting an age-dependent decrease in fibrinolytic activity. Plasma t-PA inhibitor levels also correlated significantly with serum triglyceride levels (r - 0.60, p less than 0.001), but not with coronary risk factors such as serum cholesterol, diabetes, hypertension, serum uric acid levels or body weight. Association of high levels of inhibitor of t-PA with hypertriglyceridemia may be of importance in the development of coronary thrombosis, especially in elderly patients. Nonetheless, this study does not suggest a pathogenic role of t-PA inhibitor in coronary atherosclerosis.
Similar articles
-
Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.Thromb Haemost. 1988 Dec 22;60(3):372-6. Thromb Haemost. 1988. PMID: 3149044
-
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.N Engl J Med. 1985 Dec 19;313(25):1557-63. doi: 10.1056/NEJM198512193132501. N Engl J Med. 1985. PMID: 3934538
-
Impaired fibrinolysis in coronary artery disease.Am Heart J. 1988 Apr;115(4):776-80. doi: 10.1016/0002-8703(88)90878-2. Am Heart J. 1988. PMID: 3128096
-
[Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].Helv Chir Acta. 1992 Jan;58(4):503-8. Helv Chir Acta. 1992. PMID: 1582860 German.
-
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.Dan Med Bull. 1993 Sep;40(4):383-408. Dan Med Bull. 1993. PMID: 8222763 Review.
Cited by
-
The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies.Int J Mol Sci. 2022 Nov 29;23(23):14914. doi: 10.3390/ijms232314914. Int J Mol Sci. 2022. PMID: 36499242 Free PMC article. Review.
-
Which fasting triglyceride levels best reflect coronary risk? Evidence from the Turkish Adult Risk Factor Study.Clin Cardiol. 2001 Jan;24(1):9-14. doi: 10.1002/clc.4960240103. Clin Cardiol. 2001. PMID: 11195622 Free PMC article.
-
Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease.Lipids Health Dis. 2014 Apr 27;13:73. doi: 10.1186/1476-511X-13-73. Lipids Health Dis. 2014. PMID: 24766776 Free PMC article.
-
Association of lifestyle-related factors with circadian onset patterns of acute myocardial infarction: a prospective observational study in Japan.BMJ Open. 2014 Jun 6;4(6):e005067. doi: 10.1136/bmjopen-2014-005067. BMJ Open. 2014. PMID: 24907246 Free PMC article.
-
Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.Drugs. 1989 Sep;38(3):346-88. doi: 10.2165/00003495-198938030-00003. Drugs. 1989. PMID: 2509190 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources